Bullboard - Stock Discussion Forum Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

Add To Watchlist

TSX:TRIL - Post Discussion

Trillium Therapeutics Inc. > Good opportunity

View:

Post by JamesChen on Jan 11, 2020 1:49pm

Good opportunity

As the weekend will pass, the company is expected to soar as of nearly 80% on Monday. Get your cheap shares now. No doubt due to previous trends that this had big potential.

Comment

Comment by 88guy88 on Jan 11, 2020 3:39pm

Don't think so.....unless you mean its gonna soar down 80%....that is more likely....its way way overpriced the RSI is 83.63....way way overbought as 70 is considered to be overbought...it showed signs of the buyers drying up on Friday and that will continue next week as the charts revert to the mean..... the other problem is you can't put a value on the stock as the ...more

Comment

Trillium Therapeutics Inc.